Simon Keen

Simon Keen, vice president Cell Line Development, Abzena

Articles

Transparent cell with biotechnology and cosmetic concept, 3d rendering. | Image Credit: © Vink Fan - stock.adobe.com

Optimizing Cell Line Development for Next Generation Biologics

June 18th 2024

Improving the flexibility of cell line development through utilization of platform approaches and suitable partnerships can reduce potential bottlenecks in the development pathway of novel biologics.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Published: November 22nd 2024 | Updated: November 26th 2024

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: October 28th 2024 | Updated: November 26th 2024

Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development

Published: November 15th 2024 | Updated: November 26th 2024

Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs

Published: October 28th 2024 | Updated: November 26th 2024

Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777